|
Brain Cancer Research Studies
NEWLY DIAGNOSED
R0825 Phase III
Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation
and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent
Chemoradiation and Adjuvant Temozolomide in Patients with Newly Diagnosed
Glioblastoma
RECURRENT
N0272 Phase II
Trial of Imatinib Mesylate; (Gleevec; STI-571) in Treatment of Recurrent
Oligodendroglioma and Mixed Oligoastrocytoma
N0572 A Phase
I/II Trial of Sorafenib and CCI-779 in Patients with Recurrent Glioblastoma
N0776 Phase II
Trial of Avastin in Combination with Sorafenib in Recurrent Glioblastoma
Multiforme (temporarily suspended)
N0779 Phase II
Study of Vorinostat (SAHA) in Combination with Bortezomib (PS-341) in Patients
with Recurrent Glioblastoma Multiforme
METASTATIC
N0574 Phase III
Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to
Radiosurgery in Patients with One to Three Cerebral Metastases
|